IL6 and cancer: Both in vitro and in vivo studies have been conducted, showing that, among others, Interleukin 6 (IL-6) released by the breast and prostate CSCs are responsible for maintaining a dynamic equilibrium between the cells with non-cancer stem cells (non-CSCs) [88].